An interventional study of self-cure ion-releasing bulk-fill resin composite and ion-releasing bulk-fill resin composite in Class I Dental Caries, sponsored by Mansoura University. Active, not recruiting at 1 site in Egypt. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-09-30.
Sponsored by Mansoura University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Dental Caries by Mansoura University — 5 open to participants now, 12 under way, none of them phase 3. Dental Caries · Mansoura University.
Among the 19 studies in Dental Caries by Mansoura University, this one is the 15th largest by enrollment, is one of 6 that started in 2025, is one of 19 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 18th registered.
1,176 studies on the registry are indexed under Dental Caries; 209 are open to participants now.
Browse Dental Caries studies →5 of the 19 studies in Dental Caries by Mansoura University are open now, in 1 country. Recruiting first, the newest first:
Mansoura University · Sites in Egypt
Ages 15–20
Mansoura University · Sites in Egypt
Ages 6–9
Mansoura University · Sites in Egypt
Ages 14–26
Mansoura University · Sites in Egypt
Ages 30–60 · Healthy volunteers
Mansoura University · Sites in Egypt
Ages 5–7 · Healthy volunteers
By country, each count listing its studies:
Of the 86 Dental Caries studies recruiting now, 18 (21%) set no upper age limit and 66 (77%) stop at 75 or younger; 60 take children under 18; 53 take healthy volunteers.
This study: 20 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 6 started in 2025.
This study's enrollment of 30 is below the median of 60 across 967 interventional studies indexed under Dental Caries.
Median enrollment 40 across the 19 interventional studies. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Mansoura University is the lead sponsor of 1,121 studies on the registry; 183 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
6 of the studies in Dental Caries by Mansoura University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07711132Mansoura UniversityRemineralizing Effect of Nano-eggshell, Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP), and Sodium Fluoride on Initial Enamel Caries | 2026-12-20 |
| NCT07052526Mansoura UniversityComparative Evaluation of Hydrophilic and Hydrophobic Sealants in Partially Erupted First Molars | 2027-01-01 |
| NCT06265116Mansoura UniversityOne-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations | 2027-01-23 |
| NCT07849478Mansoura UniversityTwo-year Clinical Performance of Ion-releasing and Conventional Bulk-fill Resin Composite Restorative Systems. | 2027-05 |
| NCT07849426Mansoura UniversityTwo Year Clinical Performance of Ion-releasing and Non Ion-releasing Composite Restorative Systems in Restoring Cervical Carious Lesions. | 2027-05 |
Add all 6 to your calendar (.ics) → With an account.
Among the 19 studies in Dental Caries by Mansoura University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if ion-releasing composite works to induce remineralization in caries-affected dentin in adults.
This study was designed to test the null hypothesis that there was no significant differences in: The two-year clinical performance of ion-releasing and conventional bulk-fill resin composite restorative systems.
Participants:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Eligibility Criteria
Inclusion Criteria:
Male or female gender. Only cooperative patients are approved to participate in the trial Medically free adult patients. The age range of the patients is 20- 40 years who have at least three Class I carious lesions.
Patients with normal occluusion
Exclusion Criteria:
Allergic history concerning methacrylates Pregnancy. Heavy smoking; xerostomia. Lack of compliance. Patients with disabilities. Patients who have systemic diseases or severe medically compromised patients. Patients with severe bruxism, clenching, or temporomandibular joint disorders.
Test arm
Device: self-cure ion-releasing bulk-fill resin composite
Test arm
Device: ion-releasing bulk-fill resin composite
Control arm
Device: conventional bulk-fill resin composite
class I cavity preparation and restoration with self-cure ion-releasing bulk-fill resin composite
class I cavity preparation and restoration with ion-releasing bulk-fill resin composite
class I cavity preparation and restoration with conventional bulk-fill resin composite
Clinical evaluation scores of Class I restorations according to the revised 2023 FDI criteria
FDI criteria score-Functional (F1 Fracture/Retention; F2 marginal adaptation; F5 Occlusion and wear), biological (B1 caries at restoration margin; B2 dental hard tissue defects at restoration margin; B3 Postoperative hyper-sensitivity), Aesthetic properties (A2 Marginal staining), According to the revised 2023 FDI criteria for, 1. Functional properties Restorations will be evaluated for F1 (fracture/retention), F2 (marginal adaptation), and F5 (Occlusion and wear) 2. Biological properties Restoration assessment of B1 (caries at restoration margin), B2 (dental hard tissue defects at restoration margin), and B3 Postoperative hyper-sensitivity) 3. Aesthetic properties Restorations will be evaluated for A2 (marginal staining) * Mean (SD) scores and the proportion of clinically acceptable restorations (scores 1-3) versus unacceptable restorations (scores 4-5) will be reported. Lower scores indicate better clinical performance. * Unit of Measure: FDI score
Time frame: one week, 6, 12, and 24 months
Clinical evaluation scores of Class I restorations according to the revised 2023 FDI criteria
FDI criteria score-Aesthetic properties (A1) Surface luster and surface texture, Miscellaneous properties (M1) Patient's view, according to the revised 2023 FDI criteria for, 1. Aesthetic properties: (A1) Surface luster and surface texture 2. Miscellaneous properties: (M1) Patient's view * Mean (SD) scores and the proportion of clinically acceptable restorations (scores 1-3) versus unacceptable restorations (scores 4-5) will be reported. Lower scores indicate better clinical performance. * Unit of Measure: FDI score
Time frame: one week, 6, 12, and 24 months
Started May 2025 (actual). Primary completion is estimated for May 2027, 24 months after the start.
Of 470 non-industry interventional studies with no phase under Dental Caries, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's planned 24 months is above that.
Counting every sponsor, half of 503 studies reached it within 15 months; a quarter within 7 and three quarters within 29.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.